Symbol="ITCI"
AssetType="Common Stock"
Name="Intracellular Th"
Description="Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops new drugs for the treatment of neuropsychiatric and neurological diseases and other central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York."
CIK="1567514"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="430 EAST 29TH STREET, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5973287000"
EBITDA="-238736992"
PERatio="None"
PEGRatio="0"
BookValue="6.56"
DividendPerShare="0"
DividendYield="0"
EPS="-2.46"
RevenuePerShareTTM="3.281"
ProfitMargin="-0.735"
OperatingMarginTTM="-0.771"
ReturnOnAssetsTTM="-0.188"
ReturnOnEquityTTM="-0.321"
RevenueTTM="310624000"
GrossProfitTTM="95156000"
DilutedEPSTTM="-2.46"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.723"
AnalystTargetPrice="77.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="26.09"
PriceToBookRatio="7.29"
EVToRevenue="23.48"
EVToEBITDA="-14.58"
Beta="1.096"
num_52WeekHigh="67.05"
num_52WeekLow="42.01"
num_50DayMovingAverage="63.19"
num_200DayMovingAverage="53.38"
SharesOutstanding="95926000"
DividendDate="None"
ExDividendDate="None"
symbol="ITCI"
open="64.18"
high="64.97"
low="62.07"
price="62.27"
volume="576134.00"
latest_trading_day="2023-07-07"
previous_close="64.10"
change="-1.83"
change_percent="-2.8549%"
aroon_positive_momentum_days="70"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="70"
Volume_recent_avg="803303"
Change_recent_avg="0.07"
Delta_recent_avg="1.98"
Variance_recent_avg="0.99"
Change_ratio_recent_avg="0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="70"
Aroon_momentum_negative="30"
image_negative_thumbnail_id_1="130"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_negative_thumbnail_id_2="1111"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0144.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="534"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_positive_thumbnail_id_1="950"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0112.jpeg"
image_positive_thumbnail_id_2="640"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0068.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
